Zinc oxide adhesive for IV line securement
Part of Heart & circulation, Infections, Pain, Skin clinical trials.
This trial tests a special adhesive dressing made with zinc oxide to keep your IV line secure. It looks at whether this dressing helps prevent the line from moving, which could reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to get a midline catheter or a PICC (a type of IV line).
- You must agree to be in the study and sign a consent form.
- Your hospital stay must be at least 7 days.
- You cannot be allergic to zinc oxide (the adhesive ingredient).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to lower complications from a type of IV line called a PICC, which is used for long-term treatments. You may qualify if you are independent in your daily activities and can manage your own care.
This trial studies how to make central lines safer by testing different ways to secure them and what caps to use. It is for people who need a central line, including those with cancer, and focuses on preventing infections.
This study tests a new training program for nurses and anesthesiologists to improve how they care for intravenous (IV) lines—the tubes inserted into veins to deliver medicine or fluids. Better IV line care can reduce infections and complications for patients.
This study tests if using a simple hand-extension rubber band during IV placement can help reduce pain or improve the procedure. It may be an option for right-handed adults getting an IV in specific arm veins.
This trial is testing whether a special medical adhesive and protective barrier can reduce skin damage (MARSI) from the dressing used to hold a central line in place. It is for adults in intensive care or the operating room who are getting a central line in their neck.
This trial tests whether using a special skin/line “tissue glue” around IV line sites can lower the risk of bloodstream infections in critically ill children with heart disease. It may help reduce infection rates and line-related complications in children considered high risk.
Hear when a new Vascular Access Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.